IL133137A - Pharmaceutical preparations containing 5 - [4 - (-2N) methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 2, 4 deion and sulfonyl aura - Google Patents

Pharmaceutical preparations containing 5 - [4 - (-2N) methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 2, 4 deion and sulfonyl aura

Info

Publication number
IL133137A
IL133137A IL13313798A IL13313798A IL133137A IL 133137 A IL133137 A IL 133137A IL 13313798 A IL13313798 A IL 13313798A IL 13313798 A IL13313798 A IL 13313798A IL 133137 A IL133137 A IL 133137A
Authority
IL
Israel
Prior art keywords
compound
pharmaceutically acceptable
insulin
composition according
diabetes mellitus
Prior art date
Application number
IL13313798A
Other languages
English (en)
Hebrew (he)
Other versions
IL133137A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133137(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9712854.0A external-priority patent/GB9712854D0/en
Priority claimed from GBGB9806710.1A external-priority patent/GB9806710D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL133137A0 publication Critical patent/IL133137A0/xx
Publication of IL133137A publication Critical patent/IL133137A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13313798A 1997-06-18 1998-06-15 Pharmaceutical preparations containing 5 - [4 - (-2N) methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 2, 4 deion and sulfonyl aura IL133137A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712854.0A GB9712854D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806710.1A GB9806710D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003688 WO1998057649A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (2)

Publication Number Publication Date
IL133137A0 IL133137A0 (en) 2001-03-19
IL133137A true IL133137A (en) 2004-02-08

Family

ID=26311744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13313798A IL133137A (en) 1997-06-18 1998-06-15 Pharmaceutical preparations containing 5 - [4 - (-2N) methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 2, 4 deion and sulfonyl aura

Country Status (34)

Country Link
EP (3) EP0999845B1 (ru)
JP (1) JP2001523270A (ru)
KR (3) KR20010013840A (ru)
CN (1) CN1168451C (ru)
AP (1) AP1600A (ru)
AR (2) AR008025A1 (ru)
AT (1) ATE353654T1 (ru)
AU (1) AU8539298A (ru)
BG (2) BG109397A (ru)
BR (1) BR9810142A (ru)
CA (1) CA2294385C (ru)
CO (1) CO4940457A1 (ru)
CZ (1) CZ299310B6 (ru)
DE (1) DE69837089T2 (ru)
DZ (1) DZ2522A1 (ru)
EA (1) EA003025B1 (ru)
ES (1) ES2283064T3 (ru)
HK (1) HK1028200A1 (ru)
ID (1) ID24065A (ru)
IL (1) IL133137A (ru)
IN (1) IN189319B (ru)
MA (1) MA24571A1 (ru)
MY (1) MY125855A (ru)
NO (3) NO326263B1 (ru)
NZ (1) NZ501163A (ru)
OA (1) OA11510A (ru)
PE (1) PE108199A1 (ru)
PL (2) PL337510A1 (ru)
SK (1) SK286028B6 (ru)
TR (1) TR199903096T2 (ru)
TW (1) TW542717B (ru)
UA (1) UA67743C2 (ru)
UY (1) UY25048A1 (ru)
WO (1) WO1998057649A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
EP1227818A2 (en) * 1999-11-01 2002-08-07 Wisconsin Alumni Research Foundation Abc1 modulation for the modulation of cholesterol transport
WO2002055009A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
BRPI0620020A2 (pt) 2005-12-22 2011-10-25 Takeda Pharmaceutical preparação sólida, e, partìcula revestida
CN104158867B (zh) * 2014-08-06 2017-05-17 电子科技大学 一种基于wave协议的信息多跳转发方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
HUT65619A (en) 1990-07-03 1994-07-28 Yamanouchi Pharma Co Ltd Process for producing bisheterocyclic compounds and pharmaceutical preparations containing them
KR930701420A (ko) 1990-08-23 1993-06-11 알렌 제이. 스피겔 혈당저하제로서의 하이드록시우레아 유도체
JPH04210683A (ja) 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ES2161692T3 (es) 1991-04-11 2001-12-16 Upjohn Co Derivados de tiazolidindiona, produccion y uso de los mismos.
TW222626B (ru) 1991-07-22 1994-04-21 Pfizer
FR2680512B1 (fr) 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA &amp; UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
JPH05271204A (ja) 1992-03-26 1993-10-19 Japan Tobacco Inc 新規なトリアジン誘導体
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
JPH07505647A (ja) 1992-04-10 1995-06-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 複素環化合物および２型糖尿病の治療におけるそれらの使用
AU4104593A (en) 1992-05-05 1993-11-29 Upjohn Company, The A process for producing pioglitazone metabolite
RU2134686C1 (ru) 1992-07-03 1999-08-20 Смитклайн Бичам П.Л.С. Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
TR199903096T2 (xx) 2000-08-21
TW542717B (en) 2003-07-21
CA2294385A1 (en) 1998-12-23
NO996264D0 (no) 1999-12-17
BG104058A (en) 2000-10-31
EA003025B1 (ru) 2002-12-26
IL133137A0 (en) 2001-03-19
AU8539298A (en) 1999-01-04
CZ299310B6 (cs) 2008-06-18
PL198018B1 (pl) 2008-05-30
IN189319B (ru) 2003-02-08
EP0999845B1 (en) 2007-02-14
KR20070011651A (ko) 2007-01-24
OA11510A (en) 2004-02-03
ID24065A (id) 2000-07-06
EP2266576A1 (en) 2010-12-29
CO4940457A1 (es) 2000-07-24
MY125855A (en) 2006-08-30
PL337510A1 (en) 2000-08-28
AR012996A1 (es) 2000-11-22
AP9901717A0 (en) 1999-12-31
AP1600A (en) 2006-04-28
CN1260719A (zh) 2000-07-19
EP1671637A2 (en) 2006-06-21
CZ9904577A3 (en) 2001-05-16
UY25048A1 (es) 2000-09-29
BG109397A (bg) 2006-05-31
EP1671637A3 (en) 2007-12-19
MA24571A1 (fr) 1998-12-31
SK179199A3 (en) 2000-11-07
PE108199A1 (es) 2000-01-14
KR20010013840A (ko) 2001-02-26
BG64817B1 (bg) 2006-05-31
EP0999845A1 (en) 2000-05-17
NO326263B1 (no) 2008-10-27
DZ2522A1 (fr) 2003-02-01
CN1168451C (zh) 2004-09-29
NZ501163A (en) 2002-02-01
HK1028200A1 (en) 2001-02-09
EA200000039A1 (ru) 2000-08-28
DE69837089D1 (de) 2007-03-29
SK286028B6 (sk) 2008-01-07
UA67743C2 (ru) 2004-07-15
DE69837089T2 (de) 2007-06-21
NO2009002I1 (no) 2009-03-02
ES2283064T3 (es) 2007-10-16
AR008025A1 (es) 1999-12-09
NO996264L (no) 2000-02-17
ATE353654T1 (de) 2007-03-15
CA2294385C (en) 2007-06-05
BR9810142A (pt) 2000-08-08
KR20080011356A (ko) 2008-02-01
NO20083276L (no) 2000-02-17
WO1998057649A1 (en) 1998-12-23
JP2001523270A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
EP0996444B1 (en) Treatment of diabetes with thiazolidinedione and metformin
US20080058388A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030109553A1 (en) Treatment of diabetes with thiazolidinedione and metformin
CA2296653C (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
EP0999837A1 (en) Treatment of diabetes with rosiglitazone and insulin
IL133137A (en) Pharmaceutical preparations containing 5 - [4 - (-2N) methyl - N - (2 - pyridyl) amino) ethoxy] benzyl] thiazolidine - 2, 4 deion and sulfonyl aura
AU743269B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
WO1999003478A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20040106543A1 (en) Treatment of diabetes with rosiglitazone and insulin
EP0975343A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
US20040122060A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
AU783539B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030092750A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20030073645A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
NZ518076A (en) 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM)
NZ515554A (en) Treatment of diabetes with thiazolidinedione and metformin

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees